Entero Therapeutics Rebrands as GridAI
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2025
0mins
Should l Buy ?
Name Change Announcement: Entero Therapeutics will be renamed GridAI Technologies Corp. effective December 1, 2025, at 12:01 Eastern Time.
Acquisition Alignment: The name change reflects the company's acquisition of GRID AI, which focuses on AI-driven software for managing energy resources.
Ticker Symbol Update: Along with the name change, the company's ticker symbol will change to "GRDX" and will begin trading on the Nasdaq Capital Market on the same date.
No Impact on Operations: The name and ticker change will not affect the company's legal structure, operations, or financial reporting, and shareholders do not need to take any action.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
